Harnessing analytical expertise to optimise ADC discovery and development
With the complex nature of antibody drug conjugates, analytical biochemistry is imperative to successful ADC discovery and development. At Sterling, the analytical team at our dedicated ADC facility delivers expertise in both analytical services and quality control tailored specifically to bioconjugation programmes. With extensive backgrounds in biopharmaceuticals and biochemistry, our analytical team performs comprehensive analyses on ADCs to fully understand potency and other key properties. In turn, we empower our customers to develop high-quality, highly effective therapeutics.
With deep expertise in biochemistry, bioassays, microbiology, and analytical testing, we have the capabilities needed to support a range of projects in ADC analysis. Our purpose-built facilities provide the high level of containment needed to safely handle toxic materials while working with ADCs, and our team is committed to working closely with customers to fully understand their project requirements and maximise their success. ... Read more
Our equipment and capabilities in ADC analysis include:
- HPLC methods
- Capillary Electrophoresis
- Cell based potency
- Microbiology Read less